BMRN vs COLD · P/E 40, rev $2.85B vs rev $2.67B
Biomarin Pharmaceutical Inc (BMRN) versus Americold Realty Trust (COLD) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Americold Realty Trust (COLD) is a reit - industrial company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported COLD revenue for 2024-12-31 was $2.67B. Net income was -$94.7M. Revenue was down 0.3% from 2023-12-31 to 2024-12-31. COLD currently screens at market cap $4.75B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. COLD currently screens at market cap $4.75B.
Not investment advice. Open the BMRN and COLD stock pages for the full models.
Not investment advice.